JPMorgan analyst Benjamin Rossi assumed coverage of Tenet Healthcare (THC) with an Overweight rating and $175 price target The firm believes ...

Tenet Healthcare Corporation is a prominent player in the U.S. healthcare sector, operating across three primary segments: Hospital Operations, Conifer Services, and Ambulatory Care. As of the end ...

Goldman Sachs analyst Jamie Perse downgraded Tenet Healthcare to Neutral from Buy with a price target of $140, down from $196. Amid rising ...

Tenet Healthcare is well-positioned for long-term growth due to rising healthcare demand and strategic focus on cost-efficient outpatient services. Financials show strong revenue and net income ...

15 analysts have shared their evaluations of Tenet Healthcare THC during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their recent ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.